Understanding how anxiety affects substance use in teenagers
Developmental Pathophysiology of Adverse Patterns of Substance Use in Adolescents with Anxiety
This study is looking at how anxiety and stress might affect the way teens aged 12 to 20 use substances, like alcohol or drugs, to help find better ways to support young people who are at risk of developing these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11081035 on NIH RePORTER |
What this research studies
This research investigates the relationship between anxiety symptoms and patterns of substance use in adolescents aged 12 to 20. By examining biomarkers related to neural connectivity and stress responses, the study aims to identify how these factors contribute to substance use disorders. The approach includes assessing physiological responses during stress tasks and analyzing brain activity to better understand the underlying mechanisms. The goal is to develop targeted interventions that can help prevent substance use in at-risk youth.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who exhibit symptoms of anxiety.
Not a fit: Patients outside the age range of 12 to 20 or those without anxiety symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies for substance use disorders in adolescents with anxiety.
How similar studies have performed: Previous research has shown promising results in understanding the links between anxiety and substance use, suggesting that this approach could yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Belger, Aysenil — Univ of North Carolina Chapel Hill
- Study coordinator: Belger, Aysenil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.